Literature DB >> 28636713

Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.

Gregory B Auffenberg1, Brian R Lane2, Susan Linsell1, Michael L Cher3, David C Miller1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28636713      PMCID： PMC5831460          DOI： 10.1001/jamasurg.2017.1586

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  6 in total

1.  Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.

Authors:  Paul R Womble; James E Montie; Zaojun Ye; Susan M Linsell; Brian R Lane; David C Miller
Journal:  Eur Urol       Date:  2014-08-24       Impact factor: 20.096

2.  Physician variation in management of low-risk prostate cancer: a population-based cohort study.

Authors:  Karen E Hoffman; Jiangong Niu; Yu Shen; Jing Jiang; John W Davis; Jeri Kim; Deborah A Kuban; George H Perkins; Jay B Shah; Grace L Smith; Robert J Volk; Thomas A Buchholz; Sharon H Giordano; Benjamin D Smith
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

3.  Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

Authors:  Matthew R Cooperberg; Peter R Carroll
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

4.  Prostate Cancer, Version 1.2016.

Authors:  James L Mohler; Andrew J Armstrong; Robert R Bahnson; Anthony Victor D'Amico; Brian J Davis; James A Eastham; Charles A Enke; Thomas A Farrington; Celestia S Higano; Eric M Horwitz; Michael Hurwitz; Christopher J Kane; Mark H Kawachi; Michael Kuettel; Richard J Lee; Joshua J Meeks; David F Penson; Elizabeth R Plimack; Julio M Pow-Sang; David Raben; Sylvia Richey; Mack Roach; Stan Rosenfeld; Edward Schaeffer; Ted A Skolarus; Eric J Small; Guru Sonpavde; Sandy Srinivas; Seth A Strope; Jonathan Tward; Dorothy A Shead; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2016-01       Impact factor: 11.908

5.  Appropriateness Criteria for Active Surveillance of Prostate Cancer.

Authors:  Michael L Cher; Apoorv Dhir; Gregory B Auffenberg; Susan Linsell; Yuqing Gao; Bradley Rosenberg; S Mohammad Jafri; Laurence Klotz; David C Miller; Khurshid R Ghani; Steven J Bernstein; James E Montie; Brian R Lane
Journal:  J Urol       Date:  2016-07-14       Impact factor: 7.450

6.  Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.

Authors:  Stacy Loeb; Yasin Folkvaljon; Caitlin Curnyn; David Robinson; Ola Bratt; Pär Stattin
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777
  6 in total
  17 in total

1.  Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

Authors:  Stacy Loeb; Nataliya Byrne; Danil V Makarov; Herbert Lepor; Dawn Walter
Journal:  JAMA       Date:  2018-06-05       Impact factor: 56.272

2.  Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.

Authors:  Netty Kinsella; Pär Stattin; Declan Cahill; Christian Brown; Anna Bill-Axelson; Ola Bratt; Sigrid Carlsson; Mieke Van Hemelrijck
Journal:  Eur Urol       Date:  2018-03-26       Impact factor: 20.096

Review 3.  Role of multi-parametric magnetic resonance imaging fusion biopsy in active surveillance of prostate cancer: a systematic review.

Authors:  Elizabeth E Ellis; Thomas P Frye
Journal:  Ther Adv Urol       Date:  2022-07-18

4.  Active treatment in low-risk prostate cancer: a population-based study.

Authors:  S Roy; M E Hyndman; B Danielson; A Fairey; R Lee-Ying; W Y Cheung; A R Afzal; Y Xu; T Abedin; H C Quon
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 5.  Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.

Authors:  Stacy Loeb; Nataliya K Byrne; Binhuan Wang; Danil V Makarov; Daniel Becker; David R Wise; Herbert Lepor; Dawn Walter
Journal:  Eur Urol       Date:  2020-02-22       Impact factor: 20.096

Review 6.  Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods.

Authors:  Steven Canfield; Michael J Kemeter; John Hornberger; Phillip G Febbo
Journal:  Rev Urol       Date:  2017

7.  The need for research methodology to improve acceptability of long-term surveillance for cancer.

Authors:  Netty Kinsella; Mieke Van Hemelrijck
Journal:  Transl Androl Urol       Date:  2021-06

8.  Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.

Authors:  Matthew R Cooperberg; Yingye Zheng; Anna V Faino; Lisa F Newcomb; Kehao Zhu; Janet E Cowan; James D Brooks; Atreya Dash; Martin E Gleave; Frances Martin; Todd M Morgan; Peter S Nelson; Ian M Thompson; Andrew A Wagner; Peter R Carroll; Daniel W Lin
Journal:  JAMA Oncol       Date:  2020-10-08       Impact factor: 31.777

Review 9.  The past, present, and future of urological quality improvement collaboratives.

Authors:  Adam C Reese; Serge Ginzburg
Journal:  Transl Androl Urol       Date:  2021-05

10.  Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.

Authors:  Bashir Al Hussein Al Awamlh; Neal Patel; Xiaoyue Ma; Adam Calaway; Lee Ponsky; Jim C Hu; Jonathan E Shoag
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.